Alkem Laboratories receives relief as GST demand of Rs 69.65 crore dropped on appeal
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
But acquisition charges drag earnings into loss
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Leading orthopaedic experts call for equitable insurance coverage to patients for accessing advanced, precision-driven joint replacement technologies
Subscribe To Our Newsletter & Stay Updated